:CAR-T

Yang Chen1, Ran Ren2, Lirong Yan3

  • 1Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China.

概括

化学抗原受体T细胞 (CAR-T) 疗法在固体瘤中表现有前途, 通过人工智能和CRISPR等新技术克服了挑战. 结合策略进一步增强了其在精密瘤学的潜力.